Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ICC International Cannabis Corp WLDCF

Healthcare Drug Manufacturers - Major
ICC International Cannabis Corp is a Canadian company which is engaged in planning, designing, building and operating cannabis production, processing, and distribution facilities worldwide. The company through its holdings is engaged in the pharmaceutical distribution, wholesale importation, research, and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the


OTCPK:WLDCF - Post by User

ICC International Cannabis Corp > ICC - 1 analyst with a 2.10 target for 2018
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by marexxxon Feb 20, 2017 9:35pm
224 Views
Post# 25870591

RE:ICC - 1 analyst with a 2.10 target for 2018

RE:ICC - 1 analyst with a 2.10 target for 2018"'Mackie Research Analyst Neal Gilmer gives the company a speculative buy rating and a 12 month target price of $2.10"
It is always interesting to see people who in chase of the quick profit flocking to WAAAAY overbought stocks (BE, ACB, TWMJF), and in the same time overlooking great opportunities in undervalued stock staring in their faces.
ICC is the prime example of those undervalue stocks, people need to be a little bit more patient. IMHO
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities